potential side effectsmay causepotential side effects

side effects in some animalscan causeside effects in some animals

some other side effects in them apart from those that are mentioned abovemay causesome other side effects in them apart from those that are mentioned above

Side effects and drug interaction(passive) caused bySide effects and drug interaction

side effects such as trouble sleeping , headaches , and many otherscausesside effects such as trouble sleeping , headaches , and many others

side effects in some patients such as : Pain or stinging at the application areamay causeside effects in some patients such as : Pain or stinging at the application area

the release of substances in the body that cause inflammationpreventsthe release of substances in the body that cause inflammation

any of the following side effects : burning , itching , irritation , drying , softening , and thinning of the skinmay causeany of the following side effects : burning , itching , irritation , drying , softening , and thinning of the skin

side effects such as muscle weakness , headache , dizziness , insomnia , stomach pain , dry skin , and nauseacan causeside effects such as muscle weakness , headache , dizziness , insomnia , stomach pain , dry skin , and nausea

any of the following side effects : headache , indigestion , sneezing , discomfort or irritation of the nasal passage and nose bleedmay causeany of the following side effects : headache , indigestion , sneezing , discomfort or irritation of the nasal passage and nose bleed

other side effects : muscle atrophy , loss of order CNN Ipca Laboratories 100 mg online fast delivery and appetite , depressionmay causeother side effects : muscle atrophy , loss of order CNN Ipca Laboratories 100 mg online fast delivery and appetite , depression

other side effects : muscle atrophy , loss of order Temovate GlaxoSmithKline plc 0.05 % 15 mg online fast delivery and appetite , depressionmay causeother side effects : muscle atrophy , loss of order Temovate GlaxoSmithKline plc 0.05 % 15 mg online fast delivery and appetite , depression

other side effects : muscle atrophy , loss of order Salicylic Acid Dr. Reddy 's Laboratories Ltd. 12 % 50 mg online fast delivery and appetite , depressionmay causeother side effects : muscle atrophy , loss of order Salicylic Acid Dr. Reddy 's Laboratories Ltd. 12 % 50 mg online fast delivery and appetite , depression

in increased intraocular pressure in 4 eyesresultedin increased intraocular pressure in 4 eyes

to be administered in the space located between the choroid and the scleradesignedto be administered in the space located between the choroid and the sclera

Tingling and numbnessCould ... causeTingling and numbness

Oxidative Stress - induced Tight Junction Disruption of Retinal Pigment Epithelial Cells Graefe 's Archive for Clinical and Experimental OphthalmologyPreventsOxidative Stress - induced Tight Junction Disruption of Retinal Pigment Epithelial Cells Graefe 's Archive for Clinical and Experimental Ophthalmology

to localized hypopigmentation.[36can leadto localized hypopigmentation.[36

to localized hypopigmentation.[56can leadto localized hypopigmentation.[56

elevation of blood pressure , salt and water retention ... and increased potassium and calcium excretion necessitating dietary salt restriction and potassium supplementationcan causeelevation of blood pressure , salt and water retention ... and increased potassium and calcium excretion necessitating dietary salt restriction and potassium supplementation

fetal harmcan causefetal harm

in increased expression of SULT1A1 mRNAresultsin increased expression of SULT1A1 mRNA

no treatment - related carcinogenicity at oral doses up to 0.001 mg / kg and in a two - year study in mice , triamcinolone acetonide caused no treatment - related carcinogenicity at oral doses up to 0.003 mg / kg ( less than 1/25th of the recommended human dosecausedno treatment - related carcinogenicity at oral doses up to 0.001 mg / kg and in a two - year study in mice , triamcinolone acetonide caused no treatment - related carcinogenicity at oral doses up to 0.003 mg / kg ( less than 1/25th of the recommended human dose

for intraocular usedesignedfor intraocular use

no treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults and children on a mcg / m² basis , respectivelycausedno treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults and children on a mcg / m² basis , respectively

no treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults and children on a mcg / m2 basis , respectivelycausedno treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults and children on a mcg / m2 basis , respectively

no change in pregnancy rate at oral doses up to 15 mcg where to purchase triamcinolone will 50 mg in koreacausedno change in pregnancy rate at oral doses up to 15 mcg where to purchase triamcinolone will 50 mg in korea

no treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ( approximately 1/12 and 1/30 of the maximum recommended daily intranasal dose in adults and children on a mcg / m2 basis , respectivelycausedno treatment - related carcinogenicity at oral doses up to 3.0 mcg / kg ( approximately 1/12 and 1/30 of the maximum recommended daily intranasal dose in adults and children on a mcg / m2 basis , respectively

increased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5 mcg / kg and above ( less than the maximum recommended daily intranasal dose in adults on a mcg / m2 basiscausedincreased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5 mcg / kg and above ( less than the maximum recommended daily intranasal dose in adults on a mcg / m2 basis

increased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5.0 mcg / kg and above ( less than the maximum recommended daily intranasal dose in adults on a mcg / m2basiscausedincreased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5.0 mcg / kg and above ( less than the maximum recommended daily intranasal dose in adults on a mcg / m2basis

more adverse events than bevacizumabcausesmore adverse events than bevacizumab

the progress of you or your child at regular visits for any unwanted effects(passive) may be caused bythe progress of you or your child at regular visits for any unwanted effects

to numbness TRIAMCINOLONE EUCERIN COMPOUNDleadsto numbness TRIAMCINOLONE EUCERIN COMPOUND

increased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5.0 mcg / kg and above ( approximately 1/5 of the maximum recommended daily intranasal dose in adults on a mcg / m2 basiscausedincreased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 5.0 mcg / kg and above ( approximately 1/5 of the maximum recommended daily intranasal dose in adults on a mcg / m2 basis

no change in pregnancy rate at oral doses up to 15 mcg / kg ... less than the maximum recommended daily intranasal dose in adults on a mcg / m2 basiscausedno change in pregnancy rate at oral doses up to 15 mcg / kg ... less than the maximum recommended daily intranasal dose in adults on a mcg / m2 basis

no change in pregnancy rate at oral doses up to 15.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults on a mcg / m2basiscausedno change in pregnancy rate at oral doses up to 15.0 mcg / kg ... less than the maximum recommended daily intranasal dose in adults on a mcg / m2basis

no change in pregnancy rate at oral doses up to 0.015 mg / kg ... but caused increased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 0.005 mg / kg ( less than 1/10th of the recommended human dosecausedno change in pregnancy rate at oral doses up to 0.015 mg / kg ... but caused increased fetal resorptions and stillbirths and decreases in pup weight and survival at doses of 0.005 mg / kg ( less than 1/10th of the recommended human dose

no change in pregnancy rate at oral doses up to 15.0 mcg / kg ( approximately 1/2 of the maximum recommended daily intranasal dose in adults on a mcg / m2 basiscausedno change in pregnancy rate at oral doses up to 15.0 mcg / kg ( approximately 1/2 of the maximum recommended daily intranasal dose in adults on a mcg / m2 basis

tendon sheath relief ... but also transient purplish skin discoloration and tissue atrophycausestendon sheath relief ... but also transient purplish skin discoloration and tissue atrophy

fluid and salt retention ... antihypertensive medicines used to treat high blood pressure diuretics , eg furosemidecan causefluid and salt retention ... antihypertensive medicines used to treat high blood pressure diuretics , eg furosemide